L 658310
Alternative Names: BO 1236Latest Information Update: 05 Sep 1994
At a glance
- Originator Merck & Co
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections